Endpoint security platform Kolide has picked up $17m in its Series B funding round, which was led by Boston-based venture firm OpenView Partners.
Also joining the round was Matrix Partners, which had led Kolide’s Series A, which closed in 2018.
With the support of the fresh funds, Kolide plans to enhance its go-to-market strategy and hire more engineers and product staff to build new product capabilities.
Kolide claims to differ from other endpoint security products by being working with employees to directly to fix issues it detects on Linux, Mac and Windows devices. Communication is conducted via a Slack app which messages end-users when their device no longer meets security standards established by the company. This message will include customised instructions on how to fix the problem.
It claims that this cross-platform visibility and end-user involvement enables Kolide to fix issues that are not resolvable through traditional endpoint security and management software.
The company claims its technology has seen rapid growth due to the pandemic and shift to remote working.
Kolide CEO and founder Jason Meller said, “Remote-first has created two new opposing forces. On one hand, IT and Security teams feel they need more visibility and greater control over devices out of their physical reach.
“On the other hand, employees, now at home, are starting to worry about being inappropriately surveilled, in turn driving them to use unauthorized personal devices for their work.
“The key to solving both sides of the problem is total transparency. It’s why Kolide uses an open source endpoint agent and why we’ve invested hundreds of hours creating the best possible experience for end-users to see exactly what data from devices is being collected and who in the company can see it. These are novel concepts for our industry but with Kolide, we are giving end-users, IT and Security teams a hopeful future.”
With the close of the round, the CyberTech company has raised a total of $27m in equity, to date.
Copyright © 2021 FinTech Global
